What is QMSR?
The QMSR aims to harmonize and modernize U.S. quality requirements for medical devices. The FDA specifies that manufacturers must establish and maintain a quality management system to ensure that their products consistently meet applicable requirements and defined specifications.
The QMSR is based on ISO 13485:2016, the international standard for quality management systems for medical devices, but it is not limited to mere ISO 13485 certification. Manufacturers must also take into account the specific requirements of 21 CFR Part 820, as well as other FDA requirements applicable to their products and operations.
21 CFR Part 820 specifies, among other things, that manufacturers involved in the design, manufacture, packaging, labeling, storage, installation, or post-market service of a finished device must establish and maintain a quality management system appropriate for the devices in question.
Who is affected?
The QMSR applies to manufacturers of finished medical devices intended for sale in the United States. The FDA defines a finished device as a device or device accessory that is ready for use or capable of functioning, whether or not it is packaged, labeled, or sterilized.
This applies in particular to manufacturers involved in:
- Design and development;
- Manufacturing;
- Packaging and labeling;
- Storage;
- Installation;
- After-sales service;
- Management of suppliers and subcontractors;
- Management of complaints and nonconformities;
- Management of Corrective and Preventive Actions.
Certain exemptions may apply depending on the classification and type of device.
ISO 13485 and QMSR: Harmonization, but Specific Requirements
The incorporation of ISO 13485:2016 into the QMSR facilitates alignment with the quality systems already in place at many medical device manufacturers. However, an organization that is already ISO 13485-certified must verify that its system also meets the specific requirements of the FDA.
Achieving QMSR compliance requires, in particular, an analysis of:
- The scope of the quality system with respect to activities carried out for the U.S. market;
- The applicable FDA definitions;
- Design and development requirements;
- The procedures for handling complaints;
- Requirements for quality records;
- Inspections related to labeling and packaging;
- Interactions with other applicable FDA requirements, such as those related to registration, notification, reporting, or traceability.
In fact, 21 CFR Part 820 contains provisions that supplement ISO 13485, including specific requirements regarding the handling of complaints, certain records, and controls
Our Support for Implementing the QMSR
Isocèle Conseil assists medical device manufacturers in analyzing, adapting, and implementing their quality systems in accordance with U.S. requirements.
Our services can be tailored to your level of readiness: establishing a quality system, adapting an existing ISO 13485 system, preparing for an FDA inspection, or integrating the QMSR into an international regulatory strategy.
We conduct an analysis of your existing quality system to identify any discrepancies between your current practices, ISO 13485:2016, 21 CFR Part 820, and applicable FDA requirements.
This analysis helps identify the necessary adjustments to your processes, procedures, and records, particularly in the following areas:
- Responsibilities and Quality Management;
- Document management and records control;
- Design and development;
- Production and process management;
- Supplier management;
- Identification and traceability;
- Claims Management;
- Corrective and Preventive Actions;
- Inspection of labeling and packaging;
- Preparing for FDA Inspections.
Following the gap analysis, we help you prioritize the actions to be taken based on your risk level, regulatory deadlines, and market launch objectives.
The action plan may include:
- Updating or creating procedures;
- Adapting forms and records;
- Integration of FDA requirements into existing processes;
- Clarification of internal responsibilities;
- The organization of the documented evidence expected during an inspection;
- Supporting teams in the operational implementation.
We’ll help you update your document management system to incorporate QMSR requirements in a way that aligns with your organization.
The goal is not to unnecessarily complicate the quality system, but to create clear, compliant documentation that teams can actually use.
We can provide services for:
- The quality manual or process mapping;
- Quality procedures;
- Operational instructions;
- Registration forms and templates;
- Design documents;
- Manufacturing records;
- Procedures for handling complaints, CAPA, nonconformities, and change control.
The FDA has implemented a new inspection process aligned with the QMSR requirements. As of February 2, 2026, the FDA states that it will no longer use the QSIT method for medical device inspections and will instead rely on the updated medical device manufacturer inspection program.
We help you prepare your teams and documentation to meet the requirements of an FDA inspection, specifically by:
- Review of key processes;
- Preparing quality records;
- Conducting targeted internal audits;
- Raising staff awareness of the FDA’s expectations.
Implementing the QMSR requires an operational understanding of the requirements by the quality, regulatory, R&D, production, procurement, and management teams.
We offer educational support to help you understand the key changes introduced by the QMSR, its relationship to ISO 13485:2016, and the specific requirements set forth by the FDA.